Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 21Colorectal Neoplasms 8Colonic Neoplasms 6Carcinoma, Hepatocellular 6Rectal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Unspecified Adult Solid Tumor, Protocol Specific 3Pancreatic Neoplasms 3Biliary Tract Neoplasms 3Head and Neck Neoplasms 2HER2-positive Gastric Cancer 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lung Neoplasms 1Gastric Adenocarcinoma 1Fruquintinib 1For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Efficacy and Safety 1Drug-Related Side Effects and Adverse Reactions 1Cholangiocarcinoma 1

Interventions

Rituximab 7Valganciclovir 5Valacyclovir 3Gemcitabine 3Dexamethasone 3Cisplatin 3spartalizumab 2pegaspargase 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Lenalidomide 2Etoposide 2Doxorubicin 2Cell Count 2Blood Specimen Collection 2valomaciclovir 1toripalimab 1ruxolitinib 1pembrolizumab 1merphos 1fludarabine 1dehydroftorafur 1avelumab 1apatinib 1Zidovudine 1Watchful Waiting 1Valproic Acid 1Vaccines 1Tenofovir 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Epstein-Barr Virus Infections × Tegafur × Clear all
NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

National Health Research Institutes, Taiwan

Phase 3 Terminated
10 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡